Diabetes and Obesity Drugs Surge Amid GLP-1 Demand Increase | Retatrutide News

Simply Wall Street reports on the rising demand for GLP-1 agonists, impacting diabetes and obesity drug stocks. Eli Lilly's Retatrutide is highlighted a...
Market News · October 10, 2026